AYTU icon

AYTU BioPharma

37 hedge funds and large institutions have $5.39M invested in AYTU BioPharma in 2021 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 9 increasing their positions, 15 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

more call options, than puts

Call options by funds: $ | Put options by funds: $

less ownership

Funds ownership:

less funds holding

Funds holding:

less first-time investments, than exits

New positions opened: | Existing positions closed:

40% less repeat investments, than reductions

Existing positions increased: 9 | Existing positions reduced: 15

56% less capital invested

Capital invested by funds: $12.2M → $5.39M (-$6.83M)

Holders
37
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$245K
Puts
$24K
Net Calls
Net Calls Change

Top Buyers

1 +$297K
2 +$70K
3 +$67.2K
4
TRCT
Tower Research Capital (TRC)
New York
+$36.9K
5
Two Sigma Advisers
Two Sigma Advisers
New York
+$24K

Top Sellers

1 -$254K
2 -$167K
3 -$165K
4
D.E. Shaw & Co
D.E. Shaw & Co
New York
-$113K
5
Millennium Management
Millennium Management
New York
-$87K
Name Holding Trade Value Shares
Change
Change in
Stake
1
$1.27M
2
$898K
3
$741K
4
$399K
5
$347K
6
$297K
7
$257K
8
$148K
9
$145K
10
$132K
11
$132K
12
$97K
13
$83K
14
$70K
15
$66K
16
$55K
17
$43K
18
$39K
19
$24K
20
$23K
21
$20K
22
$17K
23
$15K
24
$14K
25
$14K